Advertisement
Advertisement

NUWE

NUWE logo

Nuwellis, Inc. Common Stock

1.09
USD
Sponsored
+0.01
+1.39%
Apr 10, 15:48 UTC -4
Open

NUWE Earnings Reports

Positive Surprise Ratio

NUWE beat 17 of 37 last estimates.

46%

Next Report

Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.14M
/
-$1.02
Implied change from Q4 25 (Revenue/ EPS)
-11.89%
/
-32.00%
Implied change from Q1 25 (Revenue/ EPS)
+12.18%
/
-96.48%

Nuwellis, Inc. Common Stock earnings per share and revenue

On Mar 11, 2026, NUWE reported earnings of -1.50 USD per share (EPS) for Q4 25, beating the estimate of -1.59 USD, resulting in a 5.73% surprise. Revenue reached 2.42 million, compared to an expected 2.36 million, with a 2.88% difference. The market reacted with a +0.78% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -1.02 USD, with revenue projected to reach 2.14 million USD, implying an decrease of -32.00% EPS, and decrease of -11.89% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
logo
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
logo
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
logo
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
logo
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
logo
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
logo
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
FAQ
For Q4 2025, Nuwellis, Inc. Common Stock reported EPS of -$1.50, beating estimates by 5.73%, and revenue of $2.42M, 2.88% above expectations.
The stock price moved up 0.78%, changed from $1.29 before the earnings release to $1.30 the day after.
The next earning report is scheduled for May 11, 2026.
Based on 3 analysts, Nuwellis, Inc. Common Stock is expected to report EPS of -$1.02 and revenue of $2.14M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement